Articles

From 1 July this year, medicines containing the psychedelic substances psilocybin and MDMA can be prescribed by specifically authorised psychiatrists for the treatment of certain mental health conditions.

Before you take a weight loss supplement or medicine, there are things to consider.

The TGA has published an independent expert report examining the incidence of serious injury and death from intentional paracetamol overdose.

This labelling exemption is granted under section 1.1(3) of Part 2 of the current Poisons Standard.

This labelling exemption is granted under section 1.5.5 of Part 2 of the current Poisons Standard.

Users of nicotine vaping products are encouraged to make an appointment with their GP to discuss their smoking cessation options, ahead of changes from 1 October 2021.

From 1 October 2021, the law for consumers to import nicotine e-cigarettes and liquid nicotine will align with the law for them to buy such products domestically

The Regulation Impact Statement (RIS) and the regulatory burden costing have been published alongside the delegate's final decision on the scheduling of nicotine.

Today the TGA announced a final decision to down-schedule certain low dose cannabidiol (CBD) preparations

Pending the final outcome of the process required by law, it has been decided to defer the proposed restriction on importation of personal nicotine vaporisers and, separately, nicotine for use in e-cigarettes

Today the TGA announced an interim decision that, if made final, would clarify the regulation of e-cigarettes containing nicotine, and nicotine fluids for vaping

There will not be a decision announced on scheduling of alkyl nitrites on 29 November 2018. Further public consultation will be undertaken.

List of OTC codeine-containing products moving to prescription only

The codeine re-scheduling RIS and associated economic modelling report are now available

The Therapeutic Goods Administration has published an interim decision on a proposal to up-schedule codeine